Skip to content

Efficacy and safety of ultrasound-guided continuous thoracic paravertebral block for video-assisted thoracoscopic lobectomy in elderly patients: a multicenter, randomized controlled trial

Effects of two different anesthesia-analgesia methods on video-assisted thoracoscopic lobectomy in elderly patients: a multicenter, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051364
Enrollment
Unknown
Registered
2021-09-21
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung caner

Interventions

Control group:Simple general anesthesia and postoperative intravenous analgesia
Experimental group:Thoracic paravertebral nerve block - general combined anesthesia and postoperative continuous paravertebral analgesia

Sponsors

The First Medical Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged>=65 years; 2.Patients undergoing thoracoscopic lobectomy or partial lobectomy under general anesthesia; 3.The patient agrees to participate in the clinical study and signs the informed consent.

Exclusion criteria

Exclusion criteria: 1.Emergency surgery; 2.ASA physical status classification>=IV,BMI<=18kg/m^2 ?BMI<=30kg/m^2; 3.Patients with a history of preoperative chronic pain or abuse of psychotropic and narcotic drugs; 4.Patients with contraindications to paravertebral block anesthesia, including local infection or rash at the puncture site, long-term anticoagulant therapy or severe coagulation abnormalities; 5.Patients with sick sinus syndrome, severe sinus bradycardia (HR< 50 beats/min), or second-degree or above atrioventricular block without pacemaker; 6.Hypotension (SBP < 90mmHg, MAP < 70mmHg or SBP decreased by more than 30% from base) or expected survival < 24h; 7.Patients enrolled in other drug trials within the last 6 months; 8.Patients judged to lack the capacity for informed consent; 9.Other reasons that are considered unsuitable for study participation.

Design outcomes

Primary

MeasureTime frame
sleep quality on postoperative night;1 year postoperative survival rate;

Secondary

MeasureTime frame
pain scores;Postoperative recovery quality scale;the incidence of postoperative delirium;postoperative pulmonary complications;other postoperative complications and 30-day mortality;requirement of opioid;the sleep quality and depression/anxiety state after 1,3,12 months;incidence of postoperative chronic pain;

Countries

China

Contacts

Public ContactFu Qiang

Chinese PLA General Hospital

13691436328@163.com+86 13691436328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026